Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Withdrawal (January/February/March) | 2025

View Archived Issues

Learning Objectives, Withdrawal, CATR, January/February/March 2025

January 1, 2025

After reading these articles, you should be able to…

Effective Management of Buprenorphine-Precipitated Opioid Withdrawal

January 1, 2025

Jaewon Lee, MD, MPH

Buprenorphine is a first-line treatment for opioid use disorder, however, given buprenorphine to a patient who still has opioids in their system can precipitate severe withdrawal. Careful assessment of withdrawal can minimize the risk, but despite our best efforts, precipitated withdrawal can still occur. In this article, we review what to do for our patients experiencing buprenorphine-precipitated opioid withdrawal.

Managing Withdrawal From Multiple Substances

January 1, 2025

Darius Rastegar, MD

Substance use disorders are highly comorbid with one another and it is therefore common to have patients presenting for care withdrawing from multiple substances at one time. Here, Dr. Rastegar discusses how to assess patients with multiple withdrawal syndromes and how to treat them.

Navigating Cannabis Withdrawal

January 1, 2025

Alan J. Budney, PhD

Cannabis withdrawal is a largely underappreciated phenomenon that nonetheless interferes with many patients’ ability to stop using cannabis. Dr. Budney discusses some of the symptomatology of cannabis withdrawal and reviews how to discuss it with our patients.

Methamphetamine Withdrawal Treatment

January 1, 2025

Maryam Soltani, MD, PhD.

While stimulant withdrawal typically does not cause physiologic symptoms requiring immediate medication treatment, patients can be behaviorally challenging during this time. Here, researchers developed a protocol to treat patients withdrawing from methamphetamines on an inpatient unit.

Long-Term Patient Outcomes with Buprenorphine for Opioid Use Disorder

January 1, 2025

Peter J. Farago, MD.

Researchers compare outcomes in patients who take buprenorphine for shorter and for longer. Their findings are revealing.

CME Post-Test, Withdrawal, CATR, January/February/March 2025

January 1, 2025

By successfully completing the test you will be awarded a certificate for 2 CME credit.

Treating Opioid Use Disorder—A Fact Book (2024)
All the tools you need to assess and treat patients struggling with opioid use disorder.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
A Scam for Every Woman, Child, and Man: Part 2
1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
Listen now